Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2022 Jun 18;4(5):100681. doi: 10.1016/j.ajogmf.2022.100681

Table 3.

Intent to treat analyses stratified by GBS status and GBS prophylaxis.

Outcomes Stratified by GBS Prophylaxis Prophylactic Antibiotic Study Regimen
n=93
n (%)
Placebo
n=93
n (%)

Yes (n=42, 22.5%) n=22 n=20
 Cesarean delivery 8 (36.4) 7 (35.0)
 Puerperal Infection 2 (9.1) 0
No (n=144, 77.4%) n=71 n=73
 Cesarean delivery 19 (26.8) 30 (41.1)
 Puerperal Infection 6 (8.5) 9 (12.3)

Data are presented as n(%)